Volume 133, Issue 3, Pages (September 2007)

Slides:



Advertisements
Similar presentations
Volume 129, Issue 4, Pages (October 2005)
Advertisements

Figure 1 Body weight of control and BPA-treated mothers after delivery
Volume 150, Issue 4, Pages (April 2016)
Volume 133, Issue 2, Pages (August 2007)
Volume 131, Issue 6, Pages (December 2006)
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Kenneth G. Geles, Wenyan Zhong, Siobhan K
Volume 133, Issue 6, Pages (December 2007)
Volume 131, Issue 1, Pages (July 2006)
Whole Chromosome Instability Caused by Bub1 Insufficiency Drives Tumorigenesis through Tumor Suppressor Gene Loss of Heterozygosity  Darren J. Baker,
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 143, Issue 6, Pages (December 2012)
Volume 142, Issue 5, Pages e3 (May 2012)
Volume 136, Issue 5, Pages (May 2009)
Volume 2, Issue 4, Pages (April 2008)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Volume 131, Issue 6, Pages (December 2006)
Volume 139, Issue 6, Pages (December 2010)
Volume 131, Issue 4, Pages (October 2006)
Covering the Cover Gastroenterology
Volume 131, Issue 1, Pages (July 2006)
Volume 136, Issue 2, Pages (February 2009)
Volume 128, Issue 5, Pages (May 2005)
Volume 137, Issue 3, Pages (September 2009)
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Volume 141, Issue 4, Pages e2 (October 2011)
Notch Activation as a Driver of Osteogenic Sarcoma
Volume 132, Issue 4, Pages (April 2007)
Volume 137, Issue 4, Pages (October 2009)
Volume 136, Issue 2, Pages (February 2009)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 137, Issue 3, Pages (September 2009)
Volume 132, Issue 7, Pages (June 2007)
Volume 29, Issue 4, Pages (April 2016)
Volume 134, Issue 3, Pages (March 2008)
Volume 139, Issue 1, Pages e1 (July 2010)
Volume 14, Issue 10, Pages (March 2016)
Volume 144, Issue 2, Pages (February 2013)
Volume 126, Issue 5, Pages (May 2004)
Volume 150, Issue 4, Pages (April 2016)
Volume 141, Issue 1, Pages e4 (July 2011)
Volume 17, Issue 1, Pages (January 2010)
Volume 130, Issue 4, Pages (April 2006)
Volume 142, Issue 7, Pages e2 (June 2012)
Volume 132, Issue 1, Pages (January 2007)
Volume 137, Issue 1, Pages (July 2009)
Volume 136, Issue 3, Pages e2 (March 2009)
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Volume 138, Issue 2, Pages e2 (February 2010)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 7, Pages (June 2006)
Volume 137, Issue 4, Pages (October 2009)
Volume 17, Issue 1, Pages (January 2010)
Molecular prognostication of liver cancer: End of the beginning
Volume 138, Issue 3, Pages e5 (March 2010)
Volume 134, Issue 1, Pages (January 2008)
Volume 96, Issue 3, Pages (February 1999)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Haploinsufficiency at the Nkx3.1 locus
Long Noncoding RNAs and Hepatocellular Carcinoma
Volume 25, Issue 11, Pages (November 2017)
Volume 136, Issue 7, Pages (June 2009)
Volume 6, Issue 2, Pages (August 2004)
Volume 15, Issue 4, Pages (April 2016)
Volume 27, Issue 9, Pages (September 2019)
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Presentation transcript:

Volume 133, Issue 3, Pages 976-984 (September 2007) RB Loss Abrogates Cell Cycle Control and Genome Integrity to Promote Liver Tumorigenesis  Christopher N. Mayhew, Scott L. Carter, Sejal R. Fox, Charlene R. Sexton, Christopher A. Reed, Seetha V. Srinivasan, Xiangdong Liu, Kathryn Wikenheiser–Brokamp, Gregory P. Boivin, Ju–Seog Lee, Bruce J. Aronow, Snorri S. Thorgeirsson, Erik S. Knudsen  Gastroenterology  Volume 133, Issue 3, Pages 976-984 (September 2007) DOI: 10.1053/j.gastro.2007.06.025 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Effective RB ablation in 15-day old Rbf/f;albcre+ mice. (A) PCR analysis of genomic DNA using primers surrounding the loxP sites flanking Rb exon 19. (B) Total nuclear protein was extracted and used for immunoprecipitation/immunoblot (upper panel) or immunoblot (bottom panel) analysis of RB protein levels. Gastroenterology 2007 133, 976-984DOI: (10.1053/j.gastro.2007.06.025) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Enhanced susceptibility to liver tumorigenesis in Rbf/f;albcre+ mice exposed to DEN. Rbf/f and Rbf/f; albcre+ mice were killed 6 months post-DEN. (A) Representative images of livers of male Rbf/f and Rbf/f;albcre+ mice exposed to DEN are shown (top panel). Surface tumors were scored, and the number of lesions per liver is shown (bottom panel; mean ± SEM, n = 3 to 9). No liver lesions were detected in mice not exposed to DEN. (B) Appearance of atypical foci (left panel) and adenomas (right panel) arising in a male Rbf/f;albcre+ mouse exposed to DEN. T, tumor, N, normal tissue. (C) Adenomas arising in livers of Rbf/f and Rbf/f;albcre+ mice exposed to DEN were scored, and the number of lesions per square centimeter is shown (mean ± SEM; n = 4 to 6). (D) Representative images showing BrdU incorporation in adenomas arising in both Rbf/f and Rbf/f;albcre+ mice exposed to DEN. Top panel, original magnification, ×100; bottom panel, original magnification, ×400. Arrows indicate BrdU-positive cells in tumors (T). (E) Nuclei were isolated from tumor-free liver tissue, ploidy distribution (DNA content) was analyzed by flow cytometry, and the ratio of 4N/2N for each animal was calculated. Shown is the percentage change in this ratio for Rbf/f and Rbf/f;albcre+ mice exposed to DEN vs respective Rbf/f and Rbf/f;albcre+ controls not exposed to DEN. Mean ± SEM, n = 5 or 6 mice per group. Gastroenterology 2007 133, 976-984DOI: (10.1053/j.gastro.2007.06.025) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Tumors arising in Rbf/f;albcre+ livers exhibit elevated RB/E2F target gene expression. Rbf/f and Rbf/f;albcre+ mice were killed 9 months post-DEN. (A) Representative images of livers from male (top) and female (bottom) Rbf/f and Rbf/f;albcre+ mice exposed to DEN (left panel). Macroscopically visible surface tumors were scored, and the number of lesions per liver is shown (right panel; Mean ± SEM; n = 8 to 12). (B) Total RNA was extracted from discrete tumors and subjected to microarray analysis. The expression of 35 RB loss signature genes that exhibit significant up-regulation (P = .05; Student t test) in Rbf/f;albcre+ tumors is shown. (C) Total protein extracts were prepared from discrete tumors, and levels of the indicated proteins were assessed by immunoblotting. Gastroenterology 2007 133, 976-984DOI: (10.1053/j.gastro.2007.06.025) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Decreased genome integrity in liver tumors arising in Rbf/f;albcre+ mice exposed to DEN. Rbf/f and Rbf/f;albcre+ mice were killed 9 months post-DEN. (A) Tumor BrdU incorporation was detected by immunohistochemistry (mean ± SEM; n = 20 [Rbf/f] and 13 [Rbf/f;albcre+]). (B) A gene expression signature for RB loss is significantly enriched for genes associated with chromosomal instability. Cell cycle and CIN scores for RB loss signature genes were defined as previously described.23,24 (C) Nuclei were isolated from tumors arising in male Rbf/f and Rbf/f;albcre+ mice, and ploidy distribution was analyzed by flow cytometry. For each tumor, the percentage of nuclei with diploid or tetraploid genomes was calculated. The percentage of tumors containing cells harboring predominantly diploid (white) or tetraploid/aberrant (red) genomes is indicated. N = 16 (Rbf/f +DEN) and 29 (Rbf/f;albcre+ + DEN); *P < .05, 1-way ANOVA. Gastroenterology 2007 133, 976-984DOI: (10.1053/j.gastro.2007.06.025) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Elevated expression of RB loss signature genes predicts poor survival of HCC patients. (A) Relative expression of 137 RB loss signature genes in 139 human HCC samples. HCC tissues were ordered according to average expression level of the RB loss signature. HCC subclass indicates individuals expressing previously defined HCC subclasses A (red), B (blue), and HB (green). (B) Kaplan-Meier plot indicating the overall survival of 113 of the 139 HCC patients for which survival data were available. The total expression of RB loss signature genes for each patient was calculated, and patients were separated into 2 groups based on total expression levels that were either above (red line) or below (green line) the mean total expression of RB loss signature genes across all samples. Gastroenterology 2007 133, 976-984DOI: (10.1053/j.gastro.2007.06.025) Copyright © 2007 AGA Institute Terms and Conditions